论文信息 - A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22 - 字舞流文

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22

R. Jong | Lei Han | M. Clemons | K. Pritchard | M. Trudeau | L. Shepherd | Baoqing Guo | A. Parissenti | R. Dent | J. Chapman | H. Kahn | P. O’Brien | J. W. Chapman